Literature DB >> 19713273

Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide.

Tim J McDonald1, Bridget A Knight, Beverley M Shields, Pamela Bowman, Maurice B Salzmann, Andrew T Hattersley.   

Abstract

INTRODUCTION: C-peptide measurement in blood or 24-h urine samples provides useful information regarding endogenous insulin secretion, but problems related to the rapid degradation of C-peptide in blood and difficulty of 24-h urine collection have limited widespread routine clinical use of this test. We assessed the feasibility of measuring urinary C-peptide (UCP) with correction for creatinine concentration in single urine samples.
METHODS: We analyzed UCP using a routine electrochemiluminescence immunoassay in samples from 21 healthy volunteers. We investigated the stability of UCP with different preservatives and storage conditions and compared the reproducibility of urinary C-peptide/creatinine ratio (UCPCR) in first- and second-void fasting urines, then assessed correlations with 24-h collections.
RESULTS: UCPCR was unchanged at room temperature for 24 h and at 4 degrees C for 72 h even in the absence of preservative. UCPCR collected in boric acid was stable at room temperature for 72 h. UCPCR remained stable after 7 freeze-thaw cycles but decreased with freezer storage time and dropped to 82%-84% of baseline by 90 days at -20 degrees C. Second-void fasting UCPCRs were lower than first-void (median 0.78 vs 1.31, P = 0.0003) and showed less variation (CV 33% vs 52%), as second-void UCPCRs were not influenced by evening food-related insulin secretion. Second-void fasting UCPCR was highly correlated with 24-h UCP (r = 0.8, P = 0.00006).
CONCLUSIONS: Second-void fasting UCPCR is a reproducible measure that correlates well with 24-h UCP in normal samples. The 3-day stability of UCPCR at room temperature greatly increases its potential clinical utility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713273     DOI: 10.1373/clinchem.2009.129312

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  28 in total

1.  Significance of plasma C-peptide in obese African American adolescents.

Authors:  Gregory V Williams; Kanwal K Gambhir; Gail Nunlee-Bland; Cynthia K Abrams; Vijaya Ganta; Wolali Odonkor
Journal:  J Natl Med Assoc       Date:  2011 Sep-Oct       Impact factor: 1.798

2.  Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.

Authors:  Beverley M Shields; Maggie Shepherd; Michelle Hudson; Timothy J McDonald; Kevin Colclough; Jaime Peters; Bridget Knight; Chris Hyde; Sian Ellard; Ewan R Pearson; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

3.  Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.

Authors:  S V Hope; B A Knight; B M Shields; A T Hattersley; T J McDonald; A G Jones
Journal:  Diabet Med       Date:  2016-05-26       Impact factor: 4.359

4.  Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes.

Authors:  Maggie Shepherd; Beverley Shields; Suzanne Hammersley; Michelle Hudson; Timothy J McDonald; Kevin Colclough; Richard A Oram; Bridget Knight; Christopher Hyde; Julian Cox; Katherine Mallam; Christopher Moudiotis; Rebecca Smith; Barbara Fraser; Simon Robertson; Stephen Greene; Sian Ellard; Ewan R Pearson; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2016-06-06       Impact factor: 19.112

5.  Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.

Authors:  Richard A Oram; Timothy J McDonald; Beverley M Shields; Michelle M Hudson; Maggie H Shepherd; Suzanne Hammersley; Ewan R Pearson; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2014-12-17       Impact factor: 19.112

6.  Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin.

Authors:  Angus G Jones; Rachel Ej Besser; Beverley M Shields; Timothy J McDonald; Suzy V Hope; Bridget A Knight; Andrew T Hattersley
Journal:  BMC Endocr Disord       Date:  2012-06-08       Impact factor: 2.763

7.  Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Authors:  Rachel E J Besser; Johnny Ludvigsson; Angus G Jones; Timothy J McDonald; Beverley M Shields; Bridget A Knight; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-02-01       Impact factor: 19.112

8.  Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.

Authors:  Rachel E J Besser; Maggie H Shepherd; Timothy J McDonald; Beverley M Shields; Bridget A Knight; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

9.  Possible influence of ileal neobladder on assessment of urinary C-peptide.

Authors:  Takahiro Zenda; Masaji Miyamoto; Toshimitsu Misaki; Shuichi Kaneko
Journal:  Diabetes Care       Date:  2012-02       Impact factor: 19.112

10.  C-Peptide and vascular complications in type 2 diabetic subjects.

Authors:  Seok Man Son
Journal:  Diabetes Metab J       Date:  2012-10-18       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.